212 Drugs in development for RAI-refractory differentiated thyroid cancer. New Molecular Targets
Автор: ThyCa: Thyroid Cancer Survivors' Association, Inc.
Загружено: 2023-12-08
Просмотров: 524
212 Drugs in development for RAI-refractory differentiated thyroid cancer. New Molecular Targets. Presented by Daniel Bowles, MD, Medical Oncologist, and Mabel Ryder, MD, Endocrinologist. This video was recorded during the 26th International Thyroid Cancer Survivors' Conference that was held Oct 13-15, 2023 in Denver, Colorado, USA. This event was hosted by ThyCa: Thyroid Cancer Survivors' Association, Inc. The content is not to be used as medical advice, but rather as education. Please seek the care of your own medical team.
Доступные форматы для скачивания:
Скачать видео mp4
-
Информация по загрузке: